Doug Ethell is the founder and CEO of Leucadia Therapeutics, a pre-clinical stage company developing an early diagnostic for Alzheimer's disease and a therapeutic device to stop that disorder in its earliest stages.

Michael Levin is a biologist at Tufts University working on novel ways to understand and control complex pattern formation in biological systems. Michael Levin links Michael’s Twitter: https://twitter.com/drmichaellevin Michael’s Website: https://drmichaellevin.org PODCAST INFO: The Learning...

In this episode we are joined with  Ladan Jiracek, the host of the Neural Implant podcast and a laboratory technician and graduate student working on neural implants for peripheral nerves. Jiracek shares his insights on...

Christin Glorioso MD, Phd, & founder of NeuroAge Therapeutics and Longevity Global. Today we are digging into the drama of supplements and specifically metformin & Nir Barzilai, research into Alzheimer’s, Aubrey De Grey concerns, David...

Neuralink’s invasive brain implant vs phantom neuro’s minimally invasive muscle implant. Deep dive on brain computer interfaces, Phantom Neuro, and the future of repairing missing functions.  Connor glass Phantom is creating a human-machine interfacing system...

World Renewed C-suite executive/Operator, Executive Coach and Facilitator for venture-backed startups and other organizations ( Glassdoor, Microsoft and Headspace). She sits at the intersection point between science and human experience. She has a real superpower...

stem cell-based therapy for treating neurodegenerative conditions startup talk with Founder and CEO Subhadeep Das